Welcome to our dedicated page for Seer SEC filings (Ticker: SEER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Seer, Inc. (Nasdaq: SEER) SEC filings page provides access to the company’s official regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information on Seer’s capital structure, governance, and financial reporting practices as a life sciences company focused on deep, unbiased proteomics.
Recent Form 8-K filings include current reports on quarterly financial results, where Seer furnishes press releases describing revenue from Proteograph instruments, consumable kits, and Technology Access Center service projects. Other 8-Ks address corporate governance matters such as the election of directors, ratification of the independent registered public accounting firm, and notices related to Nasdaq listing rule compliance, including audit committee composition.
Seer’s filings also document important changes to its equity structure. A December 2025 Form 8-K describes the automatic conversion of all outstanding Class B common stock into Class A common stock pursuant to the company’s Amended and Restated Certificate of Incorporation, the subsequent retirement of the Class B shares, and the filing of a Certificate of Retirement in Delaware. The filing explains how this conversion affected voting power while leaving economic interests unchanged, and confirms that Seer’s Class A common stock continues to trade on The Nasdaq Global Select Market under the SEER ticker.
On Stock Titan, Seer’s SEC filings are updated as they are made available through EDGAR, and AI-powered summaries can help explain the key points of complex documents. Users can quickly identify items related to financial results, stock structure changes, governance decisions, and listing status, and then drill into the full filings for deeper review. This makes it easier to understand how Seer reports on its Proteograph-focused business and its obligations as a Nasdaq-listed issuer.
Seer, Inc. reported that its President & CFO, David R. Horn, sold 7,743 shares of Class A common stock in an open-market transaction at a weighted-average price of $1.9949 per share on February 18, 2026. According to the disclosure, the shares were sold to satisfy his tax obligations arising from the vesting of restricted stock units, meaning the sale was tied to a compensation-related tax event rather than a discretionary portfolio move. After this sale, he continued to hold 501,262 shares of Seer Class A common stock directly.
Seer, Inc. director, CEO and chair Omid Farokhzad reported an open-market sale of 24,385 shares of Class A common stock at an average price of $1.9949 per share on February 18, 2026. According to the filing, these shares were sold to satisfy his tax obligations arising from the vesting of restricted stock units. After this transaction, he continues to hold 3,349,064 shares directly. The filing also notes an additional 2,117,138 shares held indirectly through the SAF-BND Trust, for which his spouse is trustee, with a disclaimer of beneficial ownership except for any pecuniary interest.
Seer, Inc. reported an insider equity award to its president and CFO, David R. Horn. On February 3, 2026, he received 79,000 shares of Class A common stock in the form of restricted stock units that vest in 16 equal quarterly installments beginning on May 15, 2026. He was also granted an employee stock option to purchase 119,000 shares of Class A common stock at an exercise price of $1.79 per share, expiring on February 3, 2036. One-fourth of these option shares vest on February 3, 2027 and the remainder vests in equal monthly installments thereafter. Following these awards, Horn directly beneficially owned 509,005 shares of Class A common stock and 119,000 stock options.
Seer, Inc. CEO and Chair Omid Farokhzad reported new equity awards, including 697,162 Class A RSU-based shares and 512,000 stock options. The 697,162 reported shares are restricted stock units that vest in 16 equal quarterly installments beginning on May 15, 2026. The employee stock option covers 512,000 Class A shares at an exercise price of $1.79 per share, expiring on February 3, 2036; one-fourth vests on February 3, 2027 and the rest vests monthly thereafter. Following these grants, he directly beneficially owns 3,373,449 Class A shares, and an additional 2,117,138 shares are held by SAF-BND Trust for which his spouse is trustee, with beneficial ownership disclaimed except for any pecuniary interest.
Seer, Inc. disclosed that at the close of business on December 9, 2025, each outstanding share of its Class B common stock automatically converted into one share of Class A common stock under its Amended and Restated Certificate of Incorporation. This automatic conversion occurred at 5:00 p.m. Pacific Time and was triggered by the fifth anniversary of the company’s first firm-commitment underwritten public offering.
Immediately following the conversion, there were approximately 56,251,522 shares of Class A common stock outstanding. Former Class B holders now own the same number of Class A shares, which carry one vote per share instead of ten, equalizing voting rights while leaving economic rights unchanged. All converted Class B shares were retired, a Certificate of Retirement was filed in Delaware to reduce authorized capital and authorized Class B shares by the retired amount, and the Class A stock continues to trade on Nasdaq under the ticker “SEER.”
Seer, Inc. reported an insider transaction by a director involving the automatic conversion of 4,088 shares of Class B Common Stock into 4,088 shares of Class A Common Stock on 12/09/2025, coded as a conversion transaction. This occurred under the company’s amended and restated certificate of incorporation, which provides for each Class B share to convert into one Class A share on the first day following the fifth anniversary of the closing of Seer’s initial public offering.
After this transaction, the director is shown as beneficially owning 215,070 Class A shares indirectly through Strong Bridge, LLC, where the director serves as an operating manager, plus 112,066 Class A shares held directly and 78,947 Class A shares held indirectly through Polaris Founders Capital Fund I, L.P. The filing notes that the director and related entities disclaim beneficial ownership of the Polaris-held shares except to the extent of any pecuniary interest.
Seer, Inc. disclosed that its CEO, chair and director converted Class B Common Stock into Class A Common Stock on 12/09/2025. Under the company’s amended and restated certificate of incorporation, each Class B share automatically converted into one Class A share on the first day following the fifth anniversary of the company’s initial public offering.
The reporting person received 1,438,057 Class A shares directly and now holds 2,676,287 Class A shares in direct ownership. A further 2,117,138 Class B shares converted into the same number of Class A shares held indirectly through SAF-BND Trust, for which the reporting person’s spouse serves as trustee, with beneficial ownership disclaimed except to the extent of any pecuniary interest. All reported Class B derivative positions now show a zero balance after the conversion.
Seer, Inc. (SEER) officer David R. Horn, who serves as President & CFO, reported a tax-related sale of company stock. On 11/19/2025, he sold 6,797 shares of Class A common stock at a price of $1.9714 per share. The filing notes that these shares were sold to satisfy his tax obligations arising from the vesting of restricted stock units. After this transaction, he beneficially owned 436,802 shares of Seer Class A common stock, held directly.
Seer, Inc. (SEER) reported a routine insider transaction by its CEO and Chair, who is also a director. On 11/19/2025, the executive sold 33,838 shares of Class A common stock at a price of $1.9714 per share.
The company notes that these shares were sold to cover the reporting person's tax obligations arising from the vesting of restricted stock units. Following this transaction, the executive directly beneficially owns 1,238,230 shares of Seer common stock.
Seer, Inc. (SEER) filed its Q3 2025 report, showing steady revenue and narrowed losses. Total revenue was $4.1 million with gross profit of $2.1 million. Operating expenses fell to $21.5 million from $26.3 million a year ago, reducing the quarterly net loss to $18.2 million from $21.3 million. For the first nine months, revenue reached $12.4 million (up 22% year over year) and net loss improved to $57.6 million.
Cash, cash equivalents and investments totaled $251.2 million as of September 30, 2025, and operating cash use was $33.6 million year to date. The company repurchased 1,006,400 shares in Q3 for $2.0 million and 5,232,886 shares year to date for $10.1 million, with $3.1 million remaining under authorization. International sales represented 48% of Q3 revenue, and two customers accounted for 15% and 10% of quarterly revenue.
The company highlighted its May launch of the Proteograph ONE Assay and SP200 instrument. Class B common stock will automatically convert into Class A on December 9, 2025.